- Home
- CLSD vs MASS Comparison
CLSD vs MASS Comparison
Compare CLSD & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- MASS
- Stock Information
- Founded
- CLSD 2011
- MASS 2012
- Country
- CLSD United States
- MASS United States
- Employees
- CLSD N/A
- MASS N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- MASS Medical/Dental Instruments
- Sector
- CLSD Health Care
- MASS Health Care
- Exchange
- CLSD Nasdaq
- MASS Nasdaq
- Market Cap
- CLSD 76.6M
- MASS 77.0M
- IPO Year
- CLSD 2016
- MASS 2020
- Fundamental
- Price
- CLSD $1.01
- MASS $2.05
- Analyst Decision
- CLSD Strong Buy
- MASS Buy
- Analyst Count
- CLSD 6
- MASS 3
- Target Price
- CLSD $5.33
- MASS $8.00
- AVG Volume (30 Days)
- CLSD 230.0K
- MASS 252.2K
- Earning Date
- CLSD 11-12-2024
- MASS 11-12-2024
- Dividend Yield
- CLSD N/A
- MASS N/A
- EPS Growth
- CLSD N/A
- MASS N/A
- EPS
- CLSD N/A
- MASS N/A
- Revenue
- CLSD $7,703,000.00
- MASS $55,162,000.00
- Revenue This Year
- CLSD N/A
- MASS $15.31
- Revenue Next Year
- CLSD $91.87
- MASS $16.10
- P/E Ratio
- CLSD N/A
- MASS N/A
- Revenue Growth
- CLSD 248.39
- MASS 16.08
- 52 Week Low
- CLSD $0.92
- MASS $2.00
- 52 Week High
- CLSD $2.12
- MASS $12.51
- Technical
- Relative Strength Index (RSI)
- CLSD 42.14
- MASS 34.25
- Support Level
- CLSD $0.99
- MASS $2.01
- Resistance Level
- CLSD $1.05
- MASS $2.32
- Average True Range (ATR)
- CLSD 0.05
- MASS 0.17
- MACD
- CLSD 0.00
- MASS -0.02
- Stochastic Oscillator
- CLSD 15.38
- MASS 5.76
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About MASS 908 Devices Inc.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.